0001193805-22-001729.txt : 20221215
0001193805-22-001729.hdr.sgml : 20221215
20221215160628
ACCESSION NUMBER: 0001193805-22-001729
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221213
FILED AS OF DATE: 20221215
DATE AS OF CHANGE: 20221215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neermann Joerg
CENTRAL INDEX KEY: 0001773900
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36201
FILM NUMBER: 221464848
MAIL ADDRESS:
STREET 1: IMMUNIC AG
STREET 2: AM KLOPFERSPITZ 19
CITY: MARTINSRIED
STATE: 2M
ZIP: 82152
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNIC, INC.
CENTRAL INDEX KEY: 0001280776
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562358443
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 AVENUE OF THE AMERICAS
STREET 2: SUITE 200
CITY: NEW YORK
STATE: X1
ZIP: 10036
BUSINESS PHONE: (332) 255-9818
MAIL ADDRESS:
STREET 1: 1200 AVENUE OF THE AMERICAS
STREET 2: SUITE 200
CITY: NEW YORK
STATE: X1
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: VITAL THERAPIES INC
DATE OF NAME CHANGE: 20040219
4
1
e618126_4-jorg.xml
X0306
4
2022-12-13
0
0001280776
IMMUNIC, INC.
IMUX
0001773900
Neermann Joerg
1200 AVENUE OF THE AMERICAS, SUITE 200
NEW YORK
NY
10036
1
0
0
0
Common Stock
2022-12-13
4
P
0
35000
1.246
A
53000
D
Common Stock
2022-12-14
4
P
0
47000
1.256
A
100000
D
The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.23 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 13, 2022.
The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.22 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 14, 2022.
/s/ Joerg Neermann
2022-12-15